Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Asensus Surgical's share price for the quarter that ended in Mar. 2024 was €0.206. Asensus Surgical's Shares Outstanding (EOP) for the quarter that ended in Mar. 2024 was 271.99 Mil. Therefore, Asensus Surgical's market cap for the quarter that ended in Mar. 2024 was €56.03 Mil.
Asensus Surgical's quarterly market cap
increased
from Sep. 2023 (€65.50 Mil) to Dec. 2023 (€77.89 Mil) but then
declined
from Dec. 2023 (€77.89 Mil) to Mar. 2024 (€56.03 Mil).
Asensus Surgical's annual market cap
declined
from Dec. 2021 (€202.76 Mil) to Dec. 2022 (€67.28 Mil) but then
increased
from Dec. 2022 (€67.28 Mil) to Dec. 2023 (€77.89 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Asensus Surgical's Enterprise Value for Today is €60.29 Mil.
Asensus Surgical Market Cap Historical Data
The historical data trend for Asensus Surgical's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Asensus Surgical's Market Cap
For the Medical Devices subindustry, Asensus Surgical's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Asensus Surgical's Market Cap Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Asensus Surgical's Market Cap distribution charts can be found below:
* The bar in red indicates where Asensus Surgical's Market Cap falls into.
Asensus Surgical Market Cap Calculation
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Asensus Surgical's Market Cap for the fiscal year that ended in Dec. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Asensus Surgical (FRA:2TX) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Asensus Surgical Market Cap Related Terms
Thank you for viewing the detailed overview of Asensus Surgical's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.
Asensus Surgical Inc is a medical device company that digitizes the interface between the surgeon and the patient to improve minimally invasive surgery through digital laparoscopy. It enables the use of advanced capabilities such as augmented intelligence, connectivity, and robotics in laparoscopy and seeks to address the current clinical, cognitive, and economic shortcomings in surgery. The Senhance Surgical System is the first machine vision system for use in robotic surgery, which is powered by the new Intelligent Surgical Unit that enables augmented intelligence in surgery and brings the benefits of digital laparoscopy to patients around the world. The company's single segment includes the research, development, and sale of medical device robotics to improve minimally invasive surgery.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
FRA:2TX has been successfully added to your 